ClinicalTrials.gg
Not yet recruitingNCT06464640Updated Oct 15, 2024

Efficacy of the "Living With Type 1 Diabetes to Grown-Up" Interactive Podcast Program

An interventional study of Online Interactive Podcast Program "Living with Type 1 Diabetes to Grown-Up" and E-book in Type 1 Diabetes Mellitus, sponsored by Chang Gung University. Not yet recruiting at 1 site in Taiwan. Open to participants aged 16 Years to 25 Years. Per ClinicalTrials.gov, last updated 2024-10-15.

Sponsored by Chang Gung University · Not applicable, Interventional, and Health services research

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Randomized
Ages
16 Years to 25 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Diabetes Mellitus, Type 1 with a site in Taiwan — 1 open to participants now, 1 under way, none of them phase 3. Diabetes Mellitus, Type 1 · Taiwan.

Planned enrollment
6th of 10
88 · median 92
Started
2024
the only one that year
No phase
4 of 16
1 open now
Registered
15th of 16
by date
Lead sponsor
2 of 16
Chang Gung University

Among the 16 studies in Diabetes Mellitus, Type 1 with a site in Taiwan, this one is the 6th largest by planned enrollment of the 10 interventional ones that give a count, is the only one that started in 2024, is one of 4 with no phase, and was the 15th registered.

Diabetes Mellitus, Type 1

3,758 studies on the registry are indexed under Diabetes Mellitus, Type 1; 600 are open to participants now.

Browse Diabetes Mellitus, Type 1 studies →

Open to participants now

1 of the 16 studies in Diabetes Mellitus, Type 1 with a site in Taiwan is open now.

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 417 Diabetes Mellitus, Type 1 studies recruiting now, 130 (31%) set no upper age limit and 261 (63%) stop at 75 or younger; 187 take children under 18; 66 take healthy volunteers.

This study: 16 Years to 25 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Diabetes Mellitus, Type 1 with a site in Taiwan, or all of them as a file.
02

Study summary

The present study aims to evaluate the intervention effectiveness of the Online Interactive Podcast Program"Living with Type 1 Diabetes to Grown-Up"in patients with type 1 diabetes transitioning from adolescence to early adulthood.

Read the detailed description

Individuals aged 16-25 with Type 1 Diabetes (T1D) face significant transitional challenges in their lives, with an increased risk of worsening disease management. Addressing these challenges, an interactive podcast program,

\"Living with Type 1 Diabetes to Grown-Up\"; is being developed with a one-year grant from the National Science and Technology Council. This continued project will span three years, employing a mixed-method research design for evaluation. Participants will be recruited from pediatric endocrinology and genetics clinics and wards across two medical centers in Northern Taiwan. In line with recommendations from prior reviewers, the study will incorporate a two-phased approach: the first phase is a quantitative study, structured around transitional theory and self-regulation theory using PRIDE steps. It adopts a double-blinded, randomized controlled experimental method with data collector and sham treatment participants blinded. Subjects will be randomly assigned to either the experimental group (N=44) or the active control group (N=44). Comparative analyses will focus on variations in disease control, emotional disturbance, confidence in self-management, self-care behaviors, diabetes knowledge, interpersonal disturbance, and family conflict at baseline, and post-interventions of immediate, 3-month, and 6-month periods. In the subsequent qualitative phase, 15-20 cases from the experimental group will be selected for in-depth interviews to evaluate the impact of the \" Living with Type 1 Diabetes to GrownUp \" interactive podcast program.

The outcomes of this research are anticipated to contribute significantly to the clinical management and technological intervention strategies for T1D adolescents in their transitional phase to adulthood.

03

Conditions studied

  • Type 1 Diabetes Mellitus

Keywords

  • type 1 diabetes
  • transition
  • podcast
  • self-regulation
04

Who can participate

Ages eligible
16 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • a confirmed diagnosis of T1D by an endocrinologist before the age of 16 and a disease duration of >6months
  • patients aged 16-25 years
  • mean level ≥7.5% one year before inclusion
  • ability to communicate in Chinese or Mandarin
  • patients who own smartphones with internet access
  • patients who agreed to voice recording during a session explaining the treatment process
  • patients who signed the form prior to participation; for minors, a legal representative must provide consent and sign the informed consent form.

Exclusion criteria

Exclusion Criteria:

# T1D patients with other concomitant metabolic diseases, chromosomal aberrations, major illnesses, and cognitive impairment will be excluded from this study.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
88 participants (estimated)

Study arms

  • Experimental
    podcast intervention

    The podcast will be used for intervention in the experimental group.

    Device: Online Interactive Podcast Program "Living with Type 1 Diabetes to Grown-Up"

  • Sham comparator
    Ebook intervention

    Participants in the active control group will use E-book.

    Device: E-book

Interventions

  • DeviceOnline Interactive Podcast Program "Living with Type 1 Diabetes to Grown-Up"

    The podcast content was designed based on the results of previous research.Subjects will be randomly assigned to either the experimental group (N=44) or the comparison group (N=44). Comparative analyses will focus on variations in disease control, emotional disturbance,confidence in self-management, self-care behaviors, diabetes knowledge,interpersonal disturbance, and family conflict at baseline, and post-interventions of immediate, 3-month, and 6-month periods.

  • DeviceE-book

    Participants in the active control group will use Ebook.According to the research results from the project leader\'s app effectiveness evaluation (Chiang, 2020-2022), the e-book did not show significant effects on blood sugar control, disease management confidence, self-care behaviors, disease-related knowledge, or interpersonal distress. Therefore, the active control group received a sham treatment in the form of an e-book. The research team extracted content from the CEO APP e-book, with an expert validity of 0.91, and reorganized it into an electronic health education manual titled \"Transitioning from Adolescence to Early Adulthood: The Ins and Outs of Type 1 Diabetes.\"

06

What researchers measure

Primary outcomes

  1. Concentration of HbA1C (%) in participants

    HbA1c from baseline, 3month and 6 months

    Time frame: Baseline and 3, 6months

  2. percentage of self-monitored blood glucose readings within the 70-180 mg/dl range in Participants

    the percentage of self-monitored blood glucose levels within the optimal range of 70-180 mg/dL

    Time frame: Baseline and 3, 6months

  3. Number of Hyperglycemic Events in Participants

    Number of events of each participant with blood sugar \>200 mg/dl or" high" on glucometer, Ketoacidosis diagnosed

    Time frame: Baseline and 3, 6months

  4. Number Hypoglycemic Events in Participants

    Number of events of each participant with blood sugar \<60 mg/dl or "low" on glucometer, Hypoglycemia diagnosed

    Time frame: Baseline and 3, 6months

Secondary outcomes

  1. Score of Diabetes Distress in Participants

    Change in Diabetes Distress Scale score over time.Diabetes Distress Scale (DDS): The original scale was developed by Polonsky et al. (2005). The Chinese version consists of 18 items across four subscales. Items are scored on a 4-point Likert scale ranging from 1 (no distress) to 4 (severely distressed), with higher scores indicating more severe emotional distress. Cronbach's α and test-retest reliability values of the DDS were 0.89 and 0.81, respectively (Liu et al., 2010).

    Time frame: Baseline and 3, 6months

  2. Score of Diabetes Self-Managemen in Participants

    Perceived Diabetes Self-Management Scale (PDSMS):The original questionnaire was developed by Wallston et al. (2007). It consists of 8 items scored on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree),The translated questionnaire has content validity, Cronbach's α, and test-retest reliability values of 0.75, 0.93, and 0.97, respectively.

    Time frame: Baseline and 3, 6months

  3. Score of Diabetes Self-care in Participants

    Self-care Behavior Assessment Scale: This scale was developed by Wang (2010) to measure self-care behaviors of adolescents with T1D. A total of 39 items are scored on a 5-point Likert scale ranging from 1 (not achieved at all) to 5 (completely achieved). The total score ranges from 39 to 195, with higher scores indicating better self-care behaviors. Cronbach's α and the content validity index (CVI) value based on content rating by experts are 0.87 and 0.92, respectively.

    Time frame: Baseline and 3, 6months

  4. Score of Diabetes Knowledge in Participants

    Diabetes Knowledge Questionnaire (DKQ): The original questionnaire was developed by Garcia et al. (2001). The Chinese version comprises 24 items that are answered "Yes," "No" or "I don't know"; 1 point is awarded for each correct answer. The total score ranges from 0 to 24 points.reliability and Cronbach's α values of 0.78 and 0.89, respectively Hu et al.(2013)

    Time frame: Baseline and 3, 6months

  5. Score of Interpersonal Distress in Participants

    Analyze the score changes in the "Diabetes-Related Interpersonal Distress" subscale within the Diabetes Distress Scale (as previously mentioned in the Diabetes Distress Scale score ).

    Time frame: Baseline and 3, 6months

  6. Score of Diabetes-Related Family Conflict in Participants

    The Diabetes Family Conflict Scale-Revised (DFCS), revised by Hood et al. (2007), is used to assess family conflict and disagreements related to diabetes care in adolescents with T1D and their parents. The scale consists of 19 items and uses a 3-point scoring system: "Almost Never" scores 1 point, "Sometimes" scores 2 points, and "Almost Always" scores 3 points. Higher scores indicate more conflict. The DFCS has strong psychometric properties, with a Cronbach's α value of .95 for the adolescent version of the scale.

    Time frame: Baseline and 3, 6months

07

Study locations

1 site
  • Chang-Gung University and Chang-Gung Memorial Hospital
    Taoyuan, 33302, Taiwan
    • Yueh-Tao Chiang, PhD. · Contactnurs2004@gmail.com · +886-3-2118800
    • Fu-Sung Lo, BSN · Contactlofusu@kimo.com · +886-3-281200
    • Yueh-Tao Chiang, PhD. · Principal investigator
    • Hsing-Yi Yu, PhD. · Sub investigator
    • Chi-wen Chen, PhD. · Sub investigator
    • Chi-Wen Chang, PhD. · Sub investigator
    • Chienlung Hsu, PhD. · Sub investigator
    • Fu-Sung Lo, BSN · Principal investigator
    • Pei-kwei Tsay, PhD. · Sub investigator
    • Philip Moons, PhD. · Sub investigator
    • Wei-Hsin Ting, MS. · Sub investigator
    • Wen Yen Lin, PhD. · Sub investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2024; primary completion for Dec 2027, 37 months later.

Of 852 non-industry interventional studies with no phase under Diabetes Mellitus, Type 1, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's planned 37 months is above that.

Counting every sponsor, half of 957 studies reached it within 18 months; a quarter within 9 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2024
First posted
Jun 18, 2024
StartEst.
Nov 1, 2024
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2027
Last update
Oct 15, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06464640
Lead sponsor
Chang Gung University
Responsible party
Yueh-Tao Chiang (Assistant Professor, Chang Gung University) — Principal investigator
First posted
Jun 18, 2024
Start date
Nov 1, 2024 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 15, 2024

Study contacts

Yueh-Tao Chiang, PhD
Contact
nurs2004@gmail.com
+886-3-2118800 Ext. 3866
Fu-Sung Lo, BSN
Contact
lofusu@kimo.com
+886-3-281200 Ext. 8969
Yueh-Tao Chiang, PhD
study director · Chang Gung University
Fu-Sung Lo, BSN
study director · Chang Gung Memorial Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion